Search Results: "Turing Pharmaceuticals"
-
Salary hikes for Turing Pharmaceuticals execs, hearing points out
During today’s congressional hearing on drug pricing, Rep. Jason Chaffetz (R-Utah) made his own case […]
-
Morning Read: Turing Pharmaceuticals will lower Daraprim’s price
Turing Pharmaceuticals and Martin Shkreli blink (maybe), Anthem-Aetna Capitol Hill testimony begins, and Nestle gets deeper into the medical research.
-
Manufacturing Issues Block Astellas From a First-in-Class Cancer Drug Approval
Astellas Pharma’s zolbetuximab was on track to become the first gastric cancer drug that targets claudin 18.2, a protein found on cancerous stomach cells. Others with clinical-stage programs addressing this target include AstraZeneca and Bristol Myers Squibb.
-
Eli Lilly Jumps Into Radiopharmaceuticals via $1.4B Point Biopharma Acquisition
Acquiring Point Biopharma gives Eli Lilly a pipeline of radiopharmaceuticals, including one for prostate cancer that could rival Novartis’s Pluvicto. The deal comes ahead of an expected Phase 3 data readout for that Point therapeutic candidate.
-
Startup Syntax Bio Leverages CRISPR to Transform Cell Therapy Manufacturing
Syntax Bio’s technology platform uses CRISPR to direct stem cells to become a desired cell type in a process that’s more scalable and less expensive than current methods. The startup is raising a Series A round of financing to further demonstrate the potential of its technology.
-
MedCity Influencers, BioPharma
Meeting the needs of rare disease patients: Improved access to specialty pharmaceuticals, gene and cell therapies
Specialty carve outs that move specialty drugs away from traditional prescription drug management to a pharmacy benefit administrator (PBA) or specialty administrator will continue and likely to provide cost savings.
-
Remote service: The new paradigm for biopharma manufacturing
Microsoft seeks to change the way pharma industry companies use technology to navigate human resource challenges and restore confidence in drug development supply chains.
-
Why contract development and manufacturing for radiopharma may be a smart move
Radiopharmaceuticals are highly specialized and require equipment, facilities, personnel, licensing and training that is significantly different from traditional pharmaceutical manufacturing.
-
Vir Bio inks $362M Covid-19 contract manufacturing deal with Samsung Biologics
Vir Biotechnology, based in San Francisco, has lately made several high-profile development and manufacturing deals with drug companies as well as contract manufacturers, amid the Covid-19 pandemic. Manufacturing is expected to start in October.
-
Pfizer pours $500M into gene therapy manufacturing plant
The company said the investment would help advance work in manufacturing gene therapies that use adeno-associated viral vectors. The Sanford, North Carolina, plant is a legacy of Pfizer’s 2009 acquisition of Wyeth.
-
For CAR-Ts to be successful, figuring out manufacturing is key
Efficacy, safety and reimbursement are all important things for CAR-T makers to figure out, but manufacturing is no less important.
-
Morning Read: Valeant says at least we’re not Turing, questions about BMJ study on medical errors
Also, Chimerix reports another failed Phase 3 trial of brincidofovir, population health IT tools may become “irrelevant” and Republican healthcare policy wonks distance themselves from Trump.
-
Morning Read: Turing Pharma execs testify Martin Shkreli said, “No one cares about drug prices.”
Also, a potentially game changing approach to kidney transplants and Alphabet is selling is robotics business.
-
Catalyst Pharmaceuticals hits FDA snag for Shkreli-esque drug
The company is in trials for its drug, Firdapse, that treats LEMS. However, a generic form of that drug’s been in use for decades.
-
Morning Read: Valeant and Turing kill themselves with their own e-mails; CRISPR hits the public market with Editas’ $94M in IPO
Also, a new collar device has been designed to help protect athletes from head injuries, and it appears that the Zika virus can be sexually transmitted.